Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

WHEATON® Highlights Products at AACC 2014
Thursday, July 24, 2014
The products to be featured at the meeting offer unique solutions for the clinical market.

New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

The Hiden EQP Plasma Diagnostic with On-board MCA
Tuesday, July 22, 2014
A pure research tool specifically derived and enhanced for the plasma researcher.

ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

Tecan Launches New Options for Cavro® Omni Robot
Wednesday, July 16, 2014
Cavro Omni Robot Version 4.0 launched at the AACC’s 2014 Clinical Lab Expo.

Binding Site Chosen as Partner in the Black Swan ‘Cure Myeloma’ Research Initiative
Wednesday, July 16, 2014
Freelite® and Hevylite® will help the Black Swan Research Initiative® find the best treatment to cure multiple myeloma.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

New Magnetic Technology for Bioseparations and Studies of Biomolecular Interactions
Tuesday, July 15, 2014
AMSBIO announces MagSi-Direct - a revolutionary technology that brings the power, simplicity, and convenience of magnetic separation.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 470
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv